Research Article
Urinary Exosomal miR-193a Can Be a Potential Biomarker for the Diagnosis of Primary Focal Segmental Glomerulosclerosis in Children
Table 1
Clinical characteristics of the subjects (n = 13).
| | Patient | Age | Gender | 24-hour proteinuria | Clinical diagnosis | Pathologic diagnosis | Treatment |
| | (1) | 3 y 5 m | F | 2840 mg | SSNS | NA | PED Oral 2 mg/kg/d | | (2) | 3 y 5 m | M | 9643 mg | SSNS | NA | PED Oral 2 mg/kg/d | | (3) | 2 y 2 m | F | 1184 mg | SSNS | NA | PED Oral 2 mg/kg/d | | (4) | 1 y 10 m | F | 1064 mg | SSNS | NA | PED Oral 2 mg/kg/d | | (5) | 3 y | M | 1476 mg | SSNS | NA | PED Oral 2 mg/kg/d | | (6) | 5 y | F | 2121 mg | SRNS | FSGS (NOS) | PED Oral 2 mg/kg/d | | (7) | 12 y 11 m | M | 1477 mg | SRNS | FSGS (NOS) | PED Oral 2 mg/kg/d | | (8) | 6 y 8 m | M | 6000 mg | SRNS | FSGS (NOS) | PED Oral 2 mg/kg/d | | (9) | 9 y 2 m | M | 3522 mg | SRNS | FSGS (NOS) | PED Oral 2 mg/kg/d | | (10) | 9 y 4 m | M | 2430 mg | SRNS | FSGS (NOS) | PED Oral 2 mg/kg/d | | (11) | 5 y | M | 1438 mg | SRNS | FSGS (NOS) | PED Oral 2 mg/kg/d | | (12) | 11 y 2 m | M | 13116 mg | SRNS | FSGS (collapsing) | PED Oral 2 mg/kg/d | | (13) | 5 y | F | 1894 mg | SRNS | FSGS (NOS) | PED Oral 2 mg/kg/d |
|
|
F, female; M, male; SSNS, steroid-sensitive nephrotic syndrome; SRNS, steroid-resistant nephrotic syndrome; NOS, not otherwise specified variant; PED Oral, prednisone oral; NA, not available.
|
